|
 A spokeswoman for the Central Drugs Standard Control Organization (CDSCO)
told Reuters it was too early to say if a formal investigation would
be launched into the baby powder that is ubiquitous in many Indian
homes, a potential market of 1.3 billion people.
K. Bangarurajan, a senior official at the CDSCO, told Reuters powder
samples were tested earlier but nothing wrong was found in them.
"We tested samples in 2016, but no such thing was found in them,"
Bangarurajan said by phone. "The samples were found to be complying
with Indian standards."
A J&J spokesperson in India said it had not been contacted by the
government since the Reuters story.
J&J said in a statement that the Reuters article, which was
published on Friday, "is one-sided, false and inflammatory."
"Johnson & Johnson's baby powder is safe and asbestos free," it
added. "Studies of more than 100,000 men and women show that talc
does not cause cancer or asbestos-related disease. Thousands of
independent tests by regulators and the world’s leading labs prove
our baby powder has never contained asbestos," the company said.
A Reuters examination of many company memos, internal reports and
other confidential documents, as well as deposition and trial
testimony, showed that from at least 1971 to the early 2000s, the
company’s raw talc and finished powders sometimes tested positive
for small amounts of asbestos, and that company executives, mine
managers, scientists, doctors and lawyers fretted over the problem
and how to address it while failing to disclose it to regulators or
the public.
[to top of second column] |
The documents also depicted successful efforts to influence U.S.
regulators’ plans to limit asbestos in cosmetic talc products and
scientific research on the health effects of talc.
Before the Reuters report, a small portion of the documents had been
produced at trial and cited in media reports. Many were shielded
from public view by court orders that allowed J&J to turn over
thousands of documents it designated as confidential. Much of their
contents was reported by Reuters for the first time.
J&J said on Monday it planned to buy back up to $5 billion of its
stock, after the Reuters report wiped about $40 billion from its
market value.
(Reporting by Rahul Singh and Krishna N. Das; Edited by Martin
Howell)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
